InvestorsHub Logo
Followers 43
Posts 9124
Boards Moderated 0
Alias Born 01/06/2011

Re: SonamKapoor post# 225993

Thursday, 11/14/2019 3:03:49 PM

Thursday, November 14, 2019 3:03:49 PM

Post# of 426447
O.K. Thanks, well we already knew we were weak in this area by trial design. But a hard look at results and science by the FDA, we should have this added to the label. I'm really curious if EVAPORATE trial results coming in this weekend, added to the mix of trial data to mull over. The FDA may lean toward primary prevention. I think this drug is a preventative medicine and long term damage is cause by leaving EPA/AA ratios unchecked.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News